نتائج البحث - "Lauranne A A P Derikx"

1

دورية أكاديمية

SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis

المؤلفون: Natasja van de Pol, Qiuwei Pan, Lauranne A. A. P. Derikx, Linda Bakker, C. Janneke van der Woude, Annemarie C. de Vries

المصدر: Therapeutic Advances in Gastroenterology, Vol 16 (2023)

مصطلحات موضوعية: Diseases of the digestive system. Gastroenterology, RC799-869

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1756-2848Test

الوصول الحر: https://doaj.org/article/5e43a488fd9e4a968ac5e7726fbfb2e5Test

View record in DOAJ

النص الكامل

2

Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis

المؤلفون: Mathew Lyons, Lauranne A. A. P. Derikx, James Fulforth, Sophie McCall, Nikolas Plevris, Philip W. Jenkinson, Kathryn Kirkwood, Spyros Siakavellas, Laura Lucaciu, Nathan Constantine‐Cooke, Ian D. Arnott, Paul Henderson, Richard K. Russell, David C. Wilson, Charlie W. Lees, Gareth‐Rhys Jones

المصدر: Alimentary Pharmacology & Therapeutics, 56, 1, pp. 67-76
Lyons, M, Derikx, L A A P, Fulforth, J, Mccall, S, Plevris, N, Jenkinson, P W, Kirkwood, K, Siakavellas, S, Lucaciu, L, Constantine-cooke, N, Arnott, I D, Henderson, P, Russell, R K, Wilson, D C, Lees, C W & Jones, G 2022, ' Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: A retrospective prevalent cohort analysis ', Alimentary Pharmacology and Therapeutics . https://doi.org/10.1111/apt.16867Test
Alimentary Pharmacology & Therapeutics, 56, 67-76

مصطلحات موضوعية: Cohort Studies, Hospitalization, Biological Products, Scotland, Hepatology, Chronic Disease, Gastroenterology, Humans, Pharmacology (medical), Inflammatory Bowel Diseases, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], Aged, Retrospective Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0559ce8be2de5334c1a920751856c7Test
https://doi.org/10.1111/apt.16867Test

3

Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort

المؤلفون: Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian D. Arnott, Gareth‐Rhys Jones, Charlie W. Lees, Lauranne A. A. P. Derikx

المصدر: United European Gastroenterology Journal, 11, 2, pp. 179-188
United European Gastroenterology Journal, 11, 179-188

مصطلحات موضوعية: All institutes and research themes of the Radboud University Medical Center, Oncology, Gastroenterology, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfde6d1e9bca75e18790e9134a86c06bTest

4

Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis

المؤلفون: Edo H J Savelkoul, Pepijn W A Thomas, Lauranne A A P Derikx, Nathan den Broeder, Tessa E H Römkens, Frank Hoentjen

المصدر: Inflammatory bowel diseases.

مصطلحات موضوعية: Gastroenterology, Immunology and Allergy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ec29d805a6cc5b8d7711d60bb059bcTest
https://pubmed.ncbi.nlm.nih.gov/36318229Test

5

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naive SB5 Observational Cohorts

المؤلفون: Laura Kirckpatrick, Caitlin S Rees, Lauranne A A P Derikx, Claire O'Hare, Charlie W. Lees, Nikolas Plevris, Philip Jenkinson, S Siakavellas, Nathan Constantine-Cooke, Laura Lucaciu, Gareth-Rhys Jones, Heather W Dolby, Lynne M Merchant, Ian D. Arnott, Colin L. Noble, Shanna Su, Mathew Lyons

المصدر: Journal of Crohn's and Colitis, 15, 2011-2021
Journal of Crohn's & Colitis
Journal of Crohn's and Colitis, 15, 12, pp. 2011-2021

مصطلحات موضوعية: Crohn’s disease, Adult, Male, medicine.medical_specialty, Adolescent, Databases, Factual, Disease-Free Survival, State Medicine, Cohort Studies, 03 medical and health sciences, Young Adult, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Eccojc/1040, Gastrointestinal Agents, Internal medicine, Adalimumab, Medicine, Humans, Prospective Studies, Adverse effect, Biosimilar Pharmaceuticals, AcademicSubjects/MED00260, ulcerative colitis, Retrospective Studies, 030203 arthritis & rheumatology, business.industry, Gastroenterology, Biosimilar, General Medicine, Original Articles, medicine.disease, Inflammatory Bowel Diseases, Faecal calprotectin, Ulcerative colitis, Scotland, Cohort, 030211 gastroenterology & hepatology, Observational study, Female, biosimilar, business, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], Cohort study, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c18e73aade15417255084528433aa1Test
https://hdl.handle.net/2066/244226Test

6

Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series

المساهمون: Surgery, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and hepatology

المصدر: Journal of Crohn's & colitis, 16(6), 940-945. Elsevier
Festa, S, Zerboni, G, Derikx, L A A P, Ribaldone, D G, Dragoni, G, Buskens, C, van Dijkum, E N, Pugliese, D, Panzuto, F, Krela-Kaźmierczak, I, Mintz, H R, Shitrit, A B-G, Chaparro, M, Gisbert, J P, Kopylov, U, Teich, N, Vainer, E, Nagtegaal, I, Hoentjen, F, Garcia, M J, Filip, R, Foteinogiannopoulou, K, Koutroubakis, I E, Argollo, M, van Wanrooij, R L J, Laja, H, Lobaton, T, Truyens, M, Molnar, T, Savarino, E, Aratari, A, Papi, C & Goren, I 2022, ' Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease : An ECCO CONFER Multicentre Case Series ', Journal of Crohn's & colitis, vol. 16, no. 6, pp. 940-945 . https://doi.org/10.1093/ecco-jcc/jjab217Test
Journal of Crohn's and Colitis, 16, 6, pp. 940-945
Journal of Crohn's and Colitis, 16, 940-945

وصف الملف: text; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d72170d27eb56f218b932b74b05aa0aeTest
https://doi.org/10.1093/ecco-jcc/jjab217Test

7

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

المصدر: Journal of Crohn's and Colitis, 16, 3, pp. 389-397
Journal of Crohn's & Colitis
Journal of Crohn's and Colitis, 16, 389-397
Chanchlani, N, Lin, S, Chee, D, Hamilton, B, Nice, R, Arkir, Z, Bewshea, C, Cipriano, B, Derikx, L A A P, Dunlop, A, Greathead, L, Griffiths, R L, Ibraheim, H, Kelleher, P, Kok, K B, Lees, C W, MacDonald, J, Sebastian, S, Smith, P J, McDonald, T J, Irving, P M, Powell, N, Kennedy, N A, Goodhand, J R & Ahmad, T 2022, ' Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses : Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 389-397 . https://doi.org/10.1093/ecco-jcc/jjab153Test

مصطلحات موضوعية: Male, TNF, Gastroenterology, Serology, Seroepidemiologic Studies, adalimumab, skin and connective tissue diseases, immunosuppression, biology, medicine.diagnostic_test, General Medicine, Eccojc/1020, Original Article, Drug Monitoring, Antibody, Life Sciences & Biomedicine, biologic, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], medicine.drug, vedolizumab, Adult, medicine.medical_specialty, Combination therapy, MATURATION, Vedolizumab, DEFICIENT, inflammatory bowel disease, Internal medicine, Adalimumab, medicine, Humans, Seroprevalence, AcademicSubjects/MED00260, Biological Products, Science & Technology, Gastroenterology & Hepatology, SARS-CoV-2, business.industry, COVID-19, 1103 Clinical Sciences, vaccination, Inflammatory Bowel Diseases, Infliximab, ALPHA, Therapeutic drug monitoring, CLARITY, Antibody Formation, biology.protein, Tumor Necrosis Factor Inhibitors, infliximab, business, INFLAMMATORY-BOWEL-DISEASE